CSL (ASX:CSL) FCF Margin % : 4.70% (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is CSL FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CSL's Free Cash Flow for the six months ended in Dec. 2023 was A$548 Mil. CSL's Revenue for the six months ended in Dec. 2023 was A$11,659 Mil. Therefore, CSL's FCF Margin % for the quarter that ended in Dec. 2023 was 4.70%.

As of today, CSL's current FCF Yield % is 1.29%.

The historical rank and industry rank for CSL's FCF Margin % or its related term are showing as below:

ASX:CSL' s FCF Margin % Range Over the Past 10 Years
Min: 4.23 Med: 12.15 Max: 19.04
Current: 8.25

During the past 13 years, the highest FCF Margin % of CSL was 19.04%. The lowest was 4.23%. And the median was 12.15%.

ASX:CSL's FCF Margin % is ranked better than
85.89% of 1035 companies
in the Biotechnology industry
Industry Median: -149.8 vs ASX:CSL: 8.25

CSL FCF Margin % Historical Data

The historical data trend for CSL's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL FCF Margin % Chart

CSL Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

4.23

12.31

19.04

13.16

6.90

CSL Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															15.10	10.75	1.69	12.70	4.70

Competitive Comparison of CSL's FCF Margin %

For the Biotechnology subindustry, CSL's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSL's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CSL's FCF Margin % distribution charts can be found below:

* The bar in red indicates where CSL's FCF Margin % falls into.

CSL FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

CSL's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	1354.41	/	19629.26
	=	6.90 %

CSL's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	548.298	/	11659.176
	=	4.70 %

CSL FCF Margin % Related Terms

Thank you for viewing the detailed overview of CSL's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CSL (ASX:CSL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (ASX:CSL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

CSLLY:USA CMXHF:USA CSJ:Germany

Address

655 Elizabeth Street, Melbourne, VIC, AUS, 3000

Website

https://www.csl.com

CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.